Andera Partners — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Grey Wolf Therapeuticsgreywolftherapeutics.com inMay 2024 · $50M

Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.

BiotechDigital HealthHealthtechMedical DevicesOxford, GB

Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in

Co-investorsCanaan Partners Oxford Science Enterprises Pfizer Venture Investments British Patient Capital Earlybird Venture Capital Pfizer Ventures

Qovoltisqovoltis.com inOct 2024

Qovoltis designs, deploys, and manages electric vehicle charging infrastructure for hospitality, corporate, and residential clients.

CleantechEnergyEnterprise Software

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.